News

The new Sony Xperia 10 III It is the latest addition of the manufacturer in its new range for 2021. Along with the Xperia 1 III and Xperia 5 III we have this mid-range that for the first time also joins the rest and introduces 5G through the Qualcomm Snapdragon 690 processor.

These are the characteristics of the Sony Xperia 10 III, a mobile that stands out for its compact size, a OLED panel with 21: 9 format without hole or ‘notch’ and with the IP68 certification water resistance. A very complete mid-range that maintains many of the peculiarities that make Sony recognizable on mobile phones.

Read more

The Mac sales have reached spectacular levels as far as growth is concerned. Analysis firms IDC and Gartner have published their respective studies, yielding figures that should be analyzed in greater detail. The rest of the industry has also grown, although at a somewhat slower rate.

Read more

The quintessential item of the films of the Star Wars Universe, the coveted object of the fans of the saga, the lightsaber. As long as it has been with us for decades through movies, Disney has not yet created a real that really works like the ones in the movies. Although that could change soon, they have confirmed that they are developing a real one and retractable.

Read more

The hashflag It has already become a classic of Apple events. During the last hours, the company has activated this symbol on the social network Twitter on the occasion of the presentation on April 20. It is a practice that they have been doing for a couple of years and that serves to animate and publicize the event.

Read more

Virus RNA, part of the genetic material within a virus, can persist up to a month in the dust, according to a study conducted in rooms where COVID-19 patients were isolated.

The study did not evaluate whether the dust can transmit the virus to humans. However, it could offer another option to monitor for COVID-19 outbreaks in specific buildings.

Read more

Today was one of the most anticipated days in Spain since the vaccination campaign began: the first doses of the Janssen vaccine, from Johnson & Johnson, are beginning to arrive, long-awaited because it requires a single dose for complete vaccination and assumes in practice a cut in half of administrations necessary to get people immunized.

However, just on the day those first consignments of Janssen vials arrive in Spain, news can fall like a jug of cold water: the Center for Biological Evaluation and Research of the United States Food and Drug Administration has asked to pause the administration of this vaccine after detecting that six of the people who have received it in recent weeks have developed a disorder linked to blood clots. Six cases out of 6.8 million vaccinated.

A piece of news that reminds us of what happened with the AstraZeneca vaccine, which will no longer be inoculated in Spain to children under 60 years of age. It remains to be expected if the US government makes a firm decision in the next few hours after this health recommendation.

Read more